Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
18 hedge funds and large institutions have $9.17M invested in Neurotrope, Inc. Common in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
20% more capital invested
Capital invested by funds: $7.65M → $9.17M (+$1.52M)
18% less funds holding
Funds holding: 22 → 18 (-4)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
65% less call options, than puts
Call options by funds: $24K | Put options by funds: $69K
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tanaka Capital Management
New York
|
+$384K |
| 2 |
CC
Cannell & Co
New York
|
+$267K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$18.3K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.78K |
| 5 |
Morgan Stanley
New York
|
+$71 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$146K |
| 2 |
PWM
Paulson Wealth Management
Wheaton,
Illinois
|
-$65K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$51.5K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$24K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11K |
NTRP Hedge Fund Activity: Q1 2018 in Review
18 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q1 2018, worth a combined $9.17M — up 20% from $7.65M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NTRP and 1 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Tanaka Capital Management, adding an estimated $384K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $146K sold.
- 18 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q1 2018, down from 22 in Q4 2017.
- Funds reported $9.17M of Neurotrope, Inc. Common stock for Q1 2018, up 20% quarter-over-quarter.
- 1 fund opened new Neurotrope, Inc. Common positions in Q1 2018 and 5 closed out, a net change of -4 holders.
- The largest Neurotrope, Inc. Common buyer in Q1 2018 was Tanaka Capital Management, an estimated $384K added.
- The largest Neurotrope, Inc. Common seller in Q1 2018 was Susquehanna International Group, an estimated $146K sold.
Based on aggregated 13F filings for Q1 2018.